The Bimatoprost Drug Pad-IOL (BIM-IOL) System, developed by SpyGlass Pharma, uses 2 drug-eluting pads attached to the lens to ...
In the pivotal BRUNELLO trial, both doses of remigromig, a Wnt pathway agonist, were noninferior to ranibizumab for diabetic ...
A session at AAO 2026 highlighted how big data and minimally invasive glaucoma surgery (MIGS) could be utilized to help ...
Access to emergency eye care remains a public health challenge, with gaps that affect patients and communities across the ...
Artificial intelligence (AI) could help close gaps in eye care for underserved communities, but only if the tools reach the ...
The opening session of AAO 2026 featured a keynote speech discussing how artificial intelligence (AI) will play a part in ...
COA's Nicolas Ferreyros discusses real-world survival data for community oncology, health system consolidation, and barriers to CAR T-cell access. OneOncology's Edward "Ted" Arrowsmith, MD, MPH, ...